HUSCAP logo Hokkaido Univ. logo

Hokkaido University Collection of Scholarly and Academic Papers >
Hokkaido University Hospital >
Peer-reviewed Journal Articles, etc >

The difference between SGLT2 and DPP-4 inhibitors on glucose fluctuation in patients with type 2 diabetes

Creative Commons License

Files in This Item:
BrJRes4_21.pdf330.14 kBPDFView/Open
Please use this identifier to cite or link to this item:http://hdl.handle.net/2115/67257

Title: The difference between SGLT2 and DPP-4 inhibitors on glucose fluctuation in patients with type 2 diabetes
Authors: Nomoto, Hiroshi Browse this author
Miyoshi, Hideaki Browse this author →KAKEN DB
Keywords: Glucose fluctuation
Dipeptidyl peptidase-4 inhibitors
Sodium-glucose co-transporter 2 inhibitors
Type 2 diabetes mellitus
Issue Date: 2017
Publisher: Insight Medical Publishing
Journal Title: British Journal of Research
Volume: 4
Issue: 3
Start Page: 21
Publisher DOI: 10.21767/2394-3718.100021
Abstract: Various oral and parental hypoglycemic agents have been developed to achieve adequate glycemic control in patients with type 2 diabetes mellitus. Because of the relatively high prevalence of cardiovascular events in this patient population, it is also necessary to minimize glucose fluctuation to prevent atherosclerotic disease. Two different types of hypoglycemic agents, dipeptidyl peptidase-4 inhibitors and sodium-glucose co-transporter 2 inhibitors, appear to control glucose variability to a similar extent, but their efficacy might depend somewhat on the patient's background. To clarify which type of drug is more appropriate for use in a given patient, further investigation is needed.
Rights: https://creativecommons.org/licenses/by/3.0/
Type: article
URI: http://hdl.handle.net/2115/67257
Appears in Collections:北海道大学病院 (Hokkaido University Hospital) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)

Submitter: 三好 秀明

Export metadata:

OAI-PMH ( junii2 , jpcoar )

MathJax is now OFF:


 

Feedback - Hokkaido University